Increased PK11195 PET binding in the cortex of patients with MS correlates with disability - Wikidata - wikimedia - TriplyDB

Increased PK11195 PET binding in the cortex of patients with MS correlates with disability

Increased PK11195 PET binding in the cortex of patients with MS correlates with disability

http://www.wikidata.org/entity/Q36146941

about

Exploring potential mechanisms of action of natalizumab in secondary progressive multiple sclerosis Neuroimaging biomarkers of neurodegenerative diseases and dementia Precision Medicine in Multiple Sclerosis: Future of PET Imaging of Inflammation and Reactive Astrocytes Imaging neuroinflammation in multiple sclerosis using TSPO-PET Multiple Sclerosis and T Lymphocytes: An Entangled Story Feasibility of the use of combinatorial chemokine arrays to study blood and CSF in multiple sclerosis Neuroinflammatory component of gray matter pathology in multiple sclerosis Neuroinflammatory imaging biomarkers: relevance to multiple sclerosis and its therapy.Grey matter damage in multiple sclerosis: a pathology perspective Imaging Neuroinflammation - from Bench to Bedside.Recent imaging advances in neurology.Advances in CNS Imaging Agents: Focus on PET and SPECT Tracers in Experimental and Clinical Use.Changes and variability of proton density and T1 relaxation times in early multiple sclerosis: MRI markers of neuronal damage in the cerebral cortex.Imaging as an Outcome Measure in Multiple Sclerosis.Translocator Protein-18 kDa (TSPO) Positron Emission Tomography (PET) Imaging and Its Clinical Impact in Neurodegenerative Diseases 11C-acetate PET imaging in patients with multiple sclerosis.The role of immune cells, glia and neurons in white and gray matter pathology in multiple sclerosis.Tissue transglutaminase in marmoset experimental multiple sclerosis: discrepancy between white and grey matter.Increased PK11195-PET binding in normal-appearing white matter in clinically isolated syndrome Exploring the role of microglia in mood disorders associated with experimental multiple sclerosis LINGO-1 antibody ameliorates myelin impairment and spatial memory deficits in experimental autoimmune encephalomyelitis mice Hippocampal Neuroinflammation, Functional Connectivity, and Depressive Symptoms in Multiple Sclerosis.Positron emission tomography imaging in neurological disorders.Imaging of microglia in patients with neurodegenerative disorders.Can we switch microglia's phenotype to foster neuroprotection? Focus on multiple sclerosis.The emerging agenda of stratified medicine in neurology.PET imaging in multiple sclerosis.Positron-emission tomography molecular imaging of glia and myelin in drug discovery for multiple sclerosis.Microvesicles: What is the Role in Multiple Sclerosis?Pathological differences between white and grey matter multiple sclerosis lesions.Glucose consumption of inflammatory cells masks metabolic deficits in the brain.Advanced MRI measures like DTI or fMRI should be outcome measures in future clinical trials - YES.Spring cleaning: time to rethink imaging research lines in MS?Imaging of microglial activation in MS using PET: Research use and potential future clinical application.Myeloid cells - targets of medication in multiple sclerosis.Effect of Preventive and Curative Fingolimod Treatment Regimens on Microglia Activation and Disease Progression in a Rat Model of Multiple Sclerosis.Perfusion reduction in the absence of structural differences in cognitively impaired versus unimpaired RRMS patients.n-3 PUFA supplementation benefits microglial responses to myelin pathology.Dynamic molecular monitoring of retina inflammation by in vivo Raman spectroscopy coupled with multivariate analysis.Multiple Immune-Inflammatory and Oxidative and Nitrosative Stress Pathways Explain the Frequent Presence of Depression in Multiple Sclerosis.

P2860

Q26770818-A98B32F7-7CB1-497D-ABDE-E02094C352F6 Q27691820-4D45A75A-1937-4202-B0CE-A32BEF9F995D Q28078621-12E024E7-BDAD-4B48-8227-F119DB8C125E Q28084625-76A79C63-E671-41DD-A4CF-A0E437C6FCBB Q28086853-105EE502-E641-4E86-B201-E1E8591BD501 Q28535303-95A67E85-9E86-48A8-8E99-141FA77CC120 Q29398383-8D9E1B2C-81BA-46AF-BBBD-219EB2C55B2E Q30576477-B96B7DF0-AE3B-4F12-A692-A78B59454E30 Q30586246-1C63D054-7364-459E-9C42-CAD496821841 Q30881154-0E1EFBF0-C048-4084-A8C7-798E0E6BC1F1 Q30916063-5F48E37C-2D61-45FB-83D9-4B999C3FFBB9 Q30945416-1F422EFB-28F1-4D28-8A44-F3903AE89CEE Q31009955-9A0FFEAE-B87E-4C60-A2A0-915F56D85FDB Q31134617-7BA99365-829A-4A77-AC4F-F185A7E6E0A7 Q33624586-8D769030-7575-464B-9EC6-94889A0A1B3D Q34450336-B5EFDF27-69F7-4B75-BD64-D8C09A9D77A2 Q34468304-14B39517-32B1-4D3A-BAAA-F6F2C8ABAFBF Q35193921-6E669D5F-8223-4511-88B8-0194436C1C1E Q35248914-8D31A8C2-BF15-49B3-B677-CA6E34374879 Q35777988-9A2AE610-5126-49EC-BAFE-CCFE2A3A8B54 Q36098974-BFB3A54A-A9CF-42E6-847A-7E1F980657AF Q37032733-10D79AD4-DFF9-4868-A747-AA9320D8D966 Q37980609-CF86AD29-B864-4FA1-A4C6-2B4D3DE60FFA Q38015834-55622A07-C5BF-4E1C-A104-4007C17AA774 Q38151732-31FC8EE2-35CA-43EB-A9CF-78416A020F1B Q38169977-CA1BEC9D-585B-43D5-924C-A3F69F55AED4 Q38210272-775CCF32-D258-4AB9-9B7B-7C7B4A15036F Q38406166-A5C1686B-F959-41F7-8D8C-9AD11296997A Q38527788-BBE9C7ED-39DE-43DC-ACD3-05D524B195B9 Q38551949-8C11ECEB-6294-4E82-ACB4-FAA41C0A1569 Q38629592-047ADEEF-FC56-4370-8926-E345ABAD916D Q38664613-BD64F2BF-7AB0-4497-A3FF-4B47B6AFB8C8 Q38737202-356B25ED-56D3-4CF1-B596-5030EB3224CA Q38808948-763888ED-EB5C-4862-B736-1C25A7D60764 Q38924828-828CEEE2-F21E-4680-8E0E-2914F2963066 Q41125322-3E36D665-F409-48EC-985E-683B44E86D62 Q42578096-9FA0CF9D-0F5F-4898-931C-E11A379104EF Q42582305-361EDA63-2D33-4BB7-88E8-AB755DED5A53 Q46468264-13BA3AF4-0EC7-47FC-885D-1412B90F295F Q47559443-787DF577-694C-4192-A014-698C691CF3BD

P2860

Increased PK11195 PET binding in the cortex of patients with MS correlates with disability

http://www.wikidata.org/entity/Q36146941

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Increased PK11195 PET binding ...... MS correlates with disability

@ast

Increased PK11195 PET binding ...... MS correlates with disability

@en

type

label

Increased PK11195 PET binding ...... MS correlates with disability

@ast

Increased PK11195 PET binding ...... MS correlates with disability

@en

prefLabel

Increased PK11195 PET binding ...... MS correlates with disability

@ast

Increased PK11195 PET binding ...... MS correlates with disability

@en

P1433

Q36146941-499B7BB2-DC64-4539-B65A-0B464759802F

P1476

Q36146941-F434AD42-6517-4725-B79A-F0E6A9821139

P2093

Q36146941-061EF0AE-658C-44BB-8828-1CA3C7F0EDEE

Q36146941-13A3AAE0-AF41-4885-A2EA-047D228C9E46

Q36146941-3550E169-8C81-4732-944F-41A8148E47C8

Q36146941-35EED814-21C0-4418-9D92-D59EE172F0FA

Q36146941-451BCF1B-91C7-4181-A3EB-5A76CC1DE732

Q36146941-52D506AE-18AD-4055-B9D4-751DAF81AAD9

Q36146941-86682687-3384-4B02-B2B0-1FF057E71764

Q36146941-A3A34955-9D05-43A9-9A54-EFB91E2AE724

Q36146941-DE3F1C7C-C45F-4777-A6DA-0C33EFB5C260

P2860

Q36146941-06FF0759-A8EC-4A87-BD87-ED88889CF4B0

Q36146941-07D6FCBE-D138-424F-BCAF-BE0A668D0FBF

Q36146941-0826F1C4-431B-4C9B-B92A-A9EBDC07680F

Q36146941-1490CB14-4581-4AF7-97DC-3F3BF20C4096

Q36146941-1984828A-2884-4E5E-8111-FEC2CF710F60

Q36146941-238D7E8A-9A14-438F-A55A-A2D3CE83F0FD

Q36146941-249168E3-D19E-43E3-84C6-2A6A98D4B4F4

Q36146941-285A9CE8-102E-4ABD-931D-8193C7EF1B08

Q36146941-29BB27A4-3ED1-44CB-BFBE-749DC8D4445E

Q36146941-2E568130-B175-4F6D-AB9A-85F08AB5C0C7

P304

Q36146941-B6A70BD2-AC15-41DC-ABBD-5D8C445E650A

P31

Q36146941-338FCE13-4FC8-4C45-BF0B-11CFC5355279

P356

Q36146941-C7F03F30-D3FD-4801-A3AB-8C9BB4E9852B

P407

Q36146941-31A0F7CC-975D-4043-9D71-BD4FE044DD47

P433

Q36146941-FFD22B32-A65A-4D44-858C-7D43B4296E99

P478

Q36146941-5FAFA9B9-D50C-4F52-A4A1-32A5A32B0245

P50

Q36146941-558A9435-5C3C-474C-B5C7-474DD18AFE7E

Q36146941-B35713A7-8171-4C8E-8BD9-5819BA90F4EC

Q36146941-CBC365B3-303C-48E4-9864-4F23B2C1983B

P577

Q36146941-857CAA05-3D07-42F6-9F5C-CCD8282E60CA

P5875

Q36146941-523C356A-52E3-43A2-BA19-989A84AA6881

P698

Q36146941-5DEB0C1E-2AFB-43F3-B120-4864944B129A

P921

Q36146941-1FCC05B0-032A-4110-BD02-CF3D34305933

P932

Q36146941-6FD41248-3543-45EF-92EF-013AAD9942F6

P356

WNL.0B013E3182635645

P1433

P1476

Increased PK11195 PET binding ...... MS correlates with disability

@en

P2093

Kit Wu

http://www.w3.org/2001/XMLSchema#string

Marios Politis

http://www.w3.org/2001/XMLSchema#string

Omar Malik

http://www.w3.org/2001/XMLSchema#string

Paola Piccini

http://www.w3.org/2001/XMLSchema#string

Paolo Giannetti

http://www.w3.org/2001/XMLSchema#string

Paul Su

http://www.w3.org/2001/XMLSchema#string

Richard Nicholas

http://www.w3.org/2001/XMLSchema#string

Richard Reynolds

http://www.w3.org/2001/XMLSchema#string

Shiva Keihaninejad

http://www.w3.org/2001/XMLSchema#string

P2860

Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo

Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion

ATP mediates rapid microglial response to local brain injury in vivo

Visualising microglial activation in vivo.

Multiple sclerosis: is there neurodegeneration independent from inflammation?

Alemtuzumab vs. interferon beta-1a in early multiple sclerosis.

Microglial functions and proteases.

The brain as a target of inflammation: common pathways link inflammatory and neurodegenerative diseases.

The peripheral benzodiazepine receptor (Translocator protein 18kDa) in microglia: from pathology to imaging.

Neuronal 'On' and 'Off' signals control microglia.

P304

523-530

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1212/WNL.0B013E3182635645

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

79

http://www.w3.org/2001/XMLSchema#string

P50

Federico Turkheimer

Paul M. Matthews

P577

2012-07-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

228325134

http://www.w3.org/2001/XMLSchema#string

P698

22764258

http://www.w3.org/2001/XMLSchema#string

P921

P932

3413767

http://www.w3.org/2001/XMLSchema#string